When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LIFE - Dosing underway in aTyr Pharma's ATYR1923 study in COVID-19 patients
aTyr Pharma Inc.
ATyr Pharma (NASDAQ:LIFE) has dosed the first patient in a Phase 2 study evaluating ATYR1923, in hospitalized COVID-19 patients with severe respiratory complications who do not require mechanical ventilation.
More news on: aTyr Pharma, Inc., Healthcare stocks news,